Neurocrine Bioscience buy melinda
Start price
10.03.17
/
50%
€40.53
Target price
12.04.17
€48.71
Performance (%)
11.98%
End price
12.04.17
€45.39
Summary
This prediction ended on 12.04.17 with a price of €45.39. The prediction had a final performance of 11.98%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neurocrine Bioscience | 0.076% | 0.076% | 14.517% | 36.492% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by melinda for this prediction
In the thread Neurocrine Bioscience diskutieren
Gilles de la Tourette-Syndrom - Juvenile
folgen
(Vom Mitglied beendet)
Stopped prediction by melinda for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€98.42
25.01.21
25.01.21
€100.00
25.01.22
25.01.22
-30.50%
26.01.22
26.01.22
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€18.02
11.12.14
11.12.14
€19.50
11.06.15
11.06.15
103.97%
11.06.15
11.06.15
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€11.47
07.01.14
07.01.14
€9.50
07.07.14
07.07.14
0.60%
07.07.14
07.07.14
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€9.57
19.06.13
19.06.13
€11.00
19.12.13
19.12.13
-30.71%
19.12.13
19.12.13


